Human protease associated proteins

Details Human protease associated proteins Human protease associated proteins

2005-04-19

2005-04-19

Prouty, Rebecca (Department: 1652)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving hydrolase

C435S226000, C424S094600, C536S023200

Reexamination Certificate

active

06881552

ABSTRACT:
The invention provides human protease associated proteins (HPRAP) and polynucleotides which identify and encode HPRAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HPRAP.

REFERENCES:
patent: 0 759 467 (1997-02-01), None
patent: 0 796 913 (1997-09-01), None
patent: 0 939 131 (1999-09-01), None
patent: WO 9808866 (1998-03-01), None
M.A.F. Hayashi et al. “Species Specificity of Thimet Oligopeptidase”, Biol. Chem. Hoppe-Seyler 377: 283-291. (1996).*
Hayeshi, M.A et al. Molecular and Immunochemical Evidences Demonstrate That Endoligopeptidase A Is the Predominant Cytosolic Oligopeptidase of Rabbit Brain Biochem. Biophys. Res. Commun. 269 (1), 7-13 (2000).*
Sigma Catalog Product G 2637, (1997).*
Beynon, R.J. and J.S. Bond, (1994)Proteolytic enzymes: a practical approach.Oxford University Press, New York, NY, pp. 1-5.
Cuypers, H.T. et al., “Sulfhydryl Content of Bovine Eye Lens Leucine Aminopeptidase”,J. Biol. Chem.,257:7086-7091 (1982).
Ciechanover, A. “The Ubiquitin-Proteasome Proteolytic Pathway”,Cell,79:13-21 (1994).
Murphy, G. “The Regulation of Connective Tissue Metalloproteinases by Natural Inhibitors”,Agents Actions Suppl,35:69-76 (1991).
Calkins, C.C. and B.F. Sloane, “Mammalian Cysteine Protease Inhibitors: Biochemical Properties and Possible Roles in Tumor Progression”,Biol. Biochem. Hoppe Seyler,376:71-80 (1995).
Marlor, C.W. et al., “Identification and Cloning of Human Placental Bikunin, a Novel Serine Protease Inhibitor Containing Two Kunitz Domains”,J. Biol. Chem.,272:12202-12208 (1997) (GI 2065528; GI 2065529).
Hayashi, M.A.F. et al., (Direct Submission), GenBank Sequence Database (Accession AF015037), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894, (GI 2827885, GI 2827886).
Marlor, C.W. et al., (Direct Submission), GenBank Sequence Database (Accession U78095), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894, (GI 2065528; GI 2065529).
Tanaka, K., (Direct Submission), GenBank Sequence Database (Accession AB003177), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894, (GI 2055255; GI 2055256).
Wilson, R. et al., (Direct Submission), GenBank Sequence Database (Accession U13070), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894, (GI 529697; GI 529704, GI 529705, GI 529703, GI 529702, GI 529706, GI 529701, GI 529707, GI 529708, GI 529700, GI 529709, GI 529711, GI 529699, GI 529698, GI 529710).
Wilson, R. et al., “2.2 Mb of contiguous nucleotide sequence from chromosome III ofC. elegans”, Nature,368:32-38 (1994).
Hayashi, et al., “Endooligopeptidase A related protein”, EMBL Sequence Database, Jun. 1, 1998, XP002114379, Heidelberg, DE (Accession 046480).
Andersson et al., “Homo sapiens clone 23596 mRNA sequence”, EMBL Sequence Database, Jan. 21, 1998, XP002114381, Heidelberg, DE (Accession AF038203).
Andersson, B. et al., “A ‘Double Adaptor’ Method for Improved Shotgun Library Construction”,Anal. Biochem.,236(1):107-113 (1996).
Hillier et al., “WashU-Merck EST Project 1997”, EMBL Sequence Database, Jun. 5, 1997, XP002114382, Heidelberg, DE (Accession AA442918).
Hillier et al., “WashU-NCI human EST Project”, EMBL Sequence Database, Jan. 6, 1998, XP002114380, Heidelberg, DE (Accession AA716616).
Hillier et al., “WashU-Merck EST Project 1997”, EMBL Sequence Database, May 5, 1997, XP002114383, Heidelberg, DE (Accession AA411180).
Denda, K., “Homo sapiens mRNA for hepatocyte growth factor activator inhibitor”, EMBL Sequence Database, Mar. 10, 1998, XP002114384, Heidelberg, DE (Accession AB000095).
Shimomura et al., “Hepatocyte growth factor activator inhibitor”, EMBL Sequence Database, Jun. 1, 1998, XP002114385, Heidelberg, DE (Accession 043278).
“P27; mRNA sequence”, EMBL Sequence Database, Mar. 30, 1998, XP002114387, Heidelberg, DE (Accession AA883244).
Hillier et al., “WashU-NCI human EST Project”, EMBL Sequence Database, May 1, 1997, XP002114388, Heidelberg, DE (Accession AA402156).
Hillier et al., “WashU-NCI human EST Project”, EMBL Sequence Database, May 1, 1997, XP002114389, Heidelberg, DE (Accession AA402037).
Wilk et al., “Homo sapiens aspartyl aminopeptidase mRNA”, EMBL Sequence Database, Jan. 6, 1999, XP002114390, Heidelberg, DE (Accession AF005050).

Affiliated with

Also associated with

Rating

Human protease associated proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human protease associated proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human protease associated proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3423340